ESB Healthcare Ltd 15319217 true 2023-12-01 2024-11-30 2024-11-30 The principal activity of the company is Provision of social care services Digita Accounts Production Advanced 6.30.9574.0 true Mr Eric Esposito-Cornelio Mr Jitendra Patel Mr Richard Pockney Mr Nicolo Bacchi Mr Ralph Zhan Mr Daniele Walti true 15319217 2023-12-01 2024-11-30 15319217 2024-11-30 15319217 bus:OrdinaryShareClass1 2024-11-30 15319217 core:ShareCapital 2024-11-30 15319217 bus:FRS102 2023-12-01 2024-11-30 15319217 bus:AuditExempt-NoAccountantsReport 2023-12-01 2024-11-30 15319217 bus:FullAccounts 2023-12-01 2024-11-30 15319217 bus:RegisteredOffice 2023-12-01 2024-11-30 15319217 bus:Director1 2023-12-01 2024-11-30 15319217 bus:Director2 2023-12-01 2024-11-30 15319217 bus:Director3 2023-12-01 2024-11-30 15319217 bus:Director4 2023-12-01 2024-11-30 15319217 bus:Director5 2023-12-01 2024-11-30 15319217 bus:Director6 2023-12-01 2024-11-30 15319217 bus:OrdinaryShareClass1 2023-12-01 2024-11-30 15319217 bus:EntityHasNeverTraded 2023-12-01 2024-11-30 15319217 bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 15319217 countries:AllCountries 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 15319217

ESB Healthcare Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 30 November 2024

 

ESB Healthcare Ltd

Profit and Loss Account for the Year Ended 30 November 2024

The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

 

ESB Healthcare Ltd

(Registration number: 15319217)
Balance Sheet as at 30 November 2024

Note

2024
£

Current assets

 

Cash at bank and in hand

 

100

Capital and reserves

 

Called up share capital

4

100

Shareholders' funds

 

100

For the financial year ending 30 November 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 24 February 2025 and signed on its behalf by:
 

.........................................
Mr Eric Esposito-Cornelio
Director

 

ESB Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2024

1

General information

The company is a private company limited by share capital, incorporated in UK.

The address of its registered office is:
Carpenter Court
1 Maple Road
Bramhall
Stockport
Cheshire
SK7 2DH

These financial statements were authorised for issue by the Board on 24 February 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland and the Companies Act 2006'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

ESB Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2024

3

Cash and cash equivalents

2024
£

Cash at bank

100

4

Share capital

Allotted, called up and fully paid shares

2024

No.

£

Ordinary of £1 each

100

100